Lorazepam
1Provenance card
the boundary, as counts
Sources
3815 with DOI
16 strong · 17 moderate · 5 weak
Compilations
12026-05-09T12:23:15.751Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
41last ruled 2026-10-02
1 awaiting a ruling
Issued documents
42026-10-02T13:09:09.604Z
notice · info card · emergency
Searches
200 with no results
queries and counts on the build
Claims checked
22414 supported
14 supported · 210 not
Correspondence
0received
consent field ships in Phase 4
Edges
563
derivations recorded for this entity
Complete over 38 sources, 1 compilation, and 41 decisions.Not here: the private journal (never); 1 proposal awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/lorazepam/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-02issueIssued info_card
- 2026-10-02srcComparison of diazepam and lorazepam for the emergency treatment of adult status epilepticus: a systemic review and meta-analysis
- 2026-10-02srcThe effects of the nonselective benzodiazepine lorazepam and the α2/α3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels
- 2026-10-02srcThe Enduring Impact of Ghostwriting on the Treatment of Alcohol Withdrawal
- 2026-10-02srcManagement of Alcohol Withdrawal Syndrome in Patients with Alcoholic Liver Disease
- 2026-10-02srcReinforcing effects of compounds lacking intrinsic efficacy at α1 subunit-containing GABAA receptor subtypes in benzodiazepine-experienced monkeys
- 2026-10-02srcDiazepam-induced loss of inhibitory synapses mediated by PLCδ/Ca2+/calcineurin signalling downstream of GABAA receptors.
- 2026-10-02srcClinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (PADIS 2018)
- 2026-10-02srcTermination of seizures in the paediatric age group, best benzodiazepine and route of administration: A network meta-analysis
- 2026-10-02srcRAMPART: a double-blind randomized clinical trial of IM midazolam versus IV lorazepam for prehospital status epilepticus
- 2026-10-02srcAcute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
- 2026-10-02srcPropylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions
- 2026-10-02srcGABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.
- 2026-10-02srcBenzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches.
- 2026-10-02srcClinical Outcomes of Benzodiazepine Prescribing for People Receiving Opioid Agonist Treatment: A Systematic Review
- 2026-10-02srcEvidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults
- 2026-10-02srcEffects of tiapride on electroencephalograms and cognitive functions in the elderly
- 2026-10-02srcProlonged sedation requiring mechanical ventilation after routine doses of clorazepam - lorazepam preferred in hepatic impairment
- 2026-10-02srcA comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus
- 2026-10-02srcRWJ-51204, a new nonbenzodiazepine anxiolytic (comparison with lorazepam as full agonist)
- 2026-10-02srcEffects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels
- 2026-10-02srcEffects of lorazepam tolerance and withdrawal on GABAA receptor operated chloride channels in mice selected for differences in ethanol withdrawal severity
- 2026-10-02srcClinical pharmacokinetics of lorazepam. II. Intramuscular injection
- 2026-10-02srcSedation in PACU: the role of benzodiazepines
- 2026-10-02srcOsmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation
- 2026-10-02srcDose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration
- 2026-10-02srcGABAA receptor subtype specific enhancement of inhibition in human motor cortex
- 2026-10-02srcKinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam
- 2026-10-02srcLorazepam and FG 7142 induce tolerance to the DMCM antagonistic effect of benzodiazepine receptor ligands
- 2026-10-02srcLorazepam kinetics in the elderly
- 2026-10-02srcLorazepam - PubChem Compound CID 3958
- 2026-10-02srcPharmacokinetic study of lorazepam overdosage
- 2026-10-02srcClinical pharmacokinetics of oxazepam and lorazepam
- 2026-10-02srcPharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam
- 2026-10-02srcLorazepam and oxazepam kinetics in women on low-dose oral contraceptives
- 2026-10-02srcThe effects of benzodiazepine use during pregnancy and lactation.
- 2026-10-02srcLorazepam - Chemical Properties (PubChem CID 3958 REST API)
- 2026-10-02srcLorazepam - StatPearls
- 2026-10-02srcLorazepam - Wikipedia
- 2026-10-02publicationPublication — publishagent-psx
- 2026-10-02revisionr1.a1
- 2026-10-02rulingRuling — psx:substance/lorazepam/proposal/article_section_proposals/3e232eb7-29b9-4359-ab4d-08e719c69148founder
- 2026-10-02rulingRuling — psx:substance/lorazepam/proposal/article_section_proposals/52c42611-f6f3-489c-b36a-1aebb09d601afounder
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-07-03proposaldependence · taper
- 2026-06-04proposal34 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-09revisionRevision 1
- 2026-05-09genGeneration — pipeline-v5 · with 3 morepipeline-v5
- 2026-05-09rungeneration run
The same entries, as forms: six forms.